Home/Pipeline/Luminopia

Luminopia

Amblyopia (lazy eye) associated with anisometropia and/or strabismus

ApprovedActive

Key Facts

Indication
Amblyopia (lazy eye) associated with anisometropia and/or strabismus
Phase
Approved
Status
Active
Company

About Luminopia

Luminopia is a commercial-stage digital therapeutics company focused on revolutionizing amblyopia treatment. Its FDA-cleared, binocular therapy replaces traditional patching with an engaging one-hour daily regimen where children watch their favorite shows through a specialized VR headset, leading to high compliance and significant vision improvement. Backed by clinical data from a pivotal trial and a real-world registry, Luminopia has established a prescription-based business model and partnerships with major entertainment companies. The company is positioned to address a large pediatric market with a first-in-class product that improves both clinical outcomes and patient experience.

View full company profile

Therapeutic Areas